Analysis of the NF2 gene in oligodendrogliomas and ependymomas

Cancer Genetics and Cytogenetics

Volumn 134, Issue 1, 2002, Pages 1-5

  Alonso, M Eva ^a   Bello, M Josefa ^a   Arjona, Dolores ^a   Gonzalez Gomez, Pilar ^a   Lomas, Jesus ^a   De Campos, Jose M ^b   Kusak, M Elena ^b   Isla, Alberto ^a   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BASE MISPAIRING; CANCER GENETICS; CHROMOSOME 22; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPENDYMOMA; EXON; FEMALE; GENE INACTIVATION; GENE INSERTION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MALE; NF2 GENE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; BRAIN NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EPENDYMOMA; EXONS; HUMANS; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; MUTATION; NEUROFIBROMIN 2; OLIGODENDROGLIOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

INSERTION SEQUENCES;

EID: 0036538842     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00591-X     Document Type: Article

References (43)

1. Chromosomal patterns in human malignant astrocytomas
2. Chromosomal composition of a series of 22 human low-grade gliomas
3. Specific chromosomal abnormalities in malignant human gliomas
4. A cytogenetic study of 53 gliomas
5. Karyotypes in 90 human gliomas
6. Chromosome abnormalities in low-grade central nervous system tumors
7. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas
8. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligoastrocytomas
9. A cytogenetic study of 19 recurrent gliomas
10. Chromosome studies in 70 brain tumors with special attention to sex chromosome loss and single autosomal trisomy
11. Cytogenetic evidence for a chromosome 22 tumor suppressor gene in ependymoma
12. Chromosomes in the genesis and progression of ependymomas
13. Involvement of chromosome 22 in ependymomas
14. Chromosome aberrations in four ependymomas
15. Constitutional de novo t(1;22) (p22;q11.2) and ependymoma
16. Cytogenetic study of 33 ependymomas
17. Molecular analysis of genetic changes in ependymomas
18. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma
19. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups
20. Loss of heterozygosity for distal markers on 22q in human gliomas
21. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas
22. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene
23. Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2
24. Common regions of deletion on chromosome 22q12.3-q13.2 and 22q13.2 in human astrocytomas appear related to malignancy grade
25. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression
26. Neurofibromatosis 2. Bilateral acoustic neurofibromatosis
27. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas
28. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors
29. Analysis of the neurofibromatosis type 2 gene in different human tumors of neuroectodermal origin
30. Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas
31. Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas
32. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas
33. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningioma
34. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
35. Exon scanning for mutation of the NF2 gene in schwannomas
36. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
37. Fluorescence in situ hybridization determination of 22q12∼q13 deletion in two intracerebral ependymomas
38. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
39. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogeneic events in oligodendroglial tumors
40. Shared allelic losses on chromosome 1p and 19q suggest a common origin of oligodenedroglioma and oligoastrocytoma
41. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia
42. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas